Differences in telomerase expression by the CD1a + cells in Langerhans cell histiocytosis reflect the diverse clinical presentation of the disease
- 11 May 2007
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 212 (2) , 188-197
Abstract
Langerhans cell histiocytosis (LCH) is a disease characterized by an uncontrolled clonal proliferation of Langerhans cells, whose aetiology is still unclear. The clonal nature of LCH could support the hypothesis that it is a neoplastic disease with unlimited growth potential. One requirement for unlimited proliferation is the maintenance of telomere length. In a group of 70 patients, we set out to investigate whether a telomere maintenance mechanism is indeed active in LCH cells. This work showed that LCH cells from all restricted skin LCH lesions (6/6) expressed telomerase as assessed by human telomere reverse transcriptase (hTERT) immunohistochemistry, whereas LCH cells from the majority of the bone lesions analysed did not express hTERT (26/34). Interestingly, in contrast to the solitary bone lesions, LCH cells from lesions of multi‐system patients always expressed telomerase (11/11), regardless of the lesional site. In situ telomeric repeat amplification protocol (TRAP) assays performed on different lesional sites showed that this telomerase was active. In addition, the telomere length of LCH cells from a hTERT‐positive skin multi‐system lesion was long and homogeneous when compared to that in the LCH cells from hTERT‐negative bone single‐system LCH lesions, which was heterogeneous in length. No evidence for an alternative lengthening of telomeres mechanism was found in hTERT‐negative lesions. The difference in telomerase expression and telomere length at the different lesional sites and in biopsies from patients with solitary versus multi‐system disease appears to reflect the diverse clinical presentation and course of this disease. The results from this study have important implications for understanding the nature of this disease. Copyright © 2007 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.Keywords
This publication has 34 references indexed in Scilit:
- High‐resolution multi‐parameter DNA flow cytometry enables detection of tumour and stromal cell subpopulations in paraffin‐embedded tissuesThe Journal of Pathology, 2005
- Aberrant Chemokine Receptor Expression and Chemokine Production by Langerhans Cells Underlies the Pathogenesis of Langerhans Cell HistiocytosisJournal of Experimental Medicine, 2003
- Langerhans-cell histiocytosis 'insight into DC biology'Trends in Immunology, 2003
- Alternative lengthening of telomeres in mammalian cellsOncogene, 2002
- In situdetection of telomerase enzymatic activity in human hepatocellular carcinogenesisThe Journal of Pathology, 2001
- A survey of telomerase activity in human cancerEuropean Journal of Cancer, 1997
- Telomeres: Beginning to Understand the EndScience, 1995
- Langerhans cell histiocytosisThe Journal of Pediatrics, 1995
- Specific Association of Human Telomerase Activity with Immortal Cells and CancerScience, 1994
- Structure and function of telomeresNature, 1991